MGMT and neoplasm: Research on TMZ treatment resistance has identified several contributing factors, such as elevated levels of MGMT (O6-methylguanine-DNA methyltransferase), increased activity of DNA repair pathways, the presence of tumor stem cells, and the role of drug efflux transporters [8, 9].